Article
KatG catalase deficiency confers bedaquiline hyper-susceptibility to isoniazid resistant <i>Mycobacterium tuberculosis</i>
2023-10-17
Abstract excerpt
<h4>ABSTRACT</h4> Multidrug-resistant tuberculosis (MDR-TB) is a growing source of global mortality and threatens global control of tuberculosis (TB) disease. The diarylquinoline bedaquiline (BDQ) recently emerged as a highly efficacious drug against MDR-TB, defined as resistance to the first-line drugs isoniazid (INH) and rifampin. INH resistance is primarily caused by loss-of-function mutations in the catalase...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bf8a17b0-c9d1-53f1-ba6c-a3e54050040f
- DOI
- 10.1101/2023.10.17.562707
